L01FX
Spain- L01FX02 1 medications
- L01FX04 2 medications
- L01FX05 1 medications
- L01FX06 1 medications
- L01FX07 1 medications
- L01FX08 1 medications
- L01FX09 1 medications
- L01FX12 1 medications
- L01FX13 2 medications
- L01FX14 2 medications
- L01FX17 1 medications
- L01FX18 3 medications
- L01FX20 1 medications
- L01FX24 2 medications
- L01FX25 2 medications
- L01FX27 2 medications
- L01FX28 2 medications
- L01FX29 2 medications
- L01FX32 1 medications
medicationsWithCode L01FX
-
Adcetris 50 mg powder for concentrate for infusion solution
Form: powder for concentrate for solution for infusion
Active substance Dosage BRENTUXIMAB VEDOTIN 50 mg ATC code: L01F, L01FX, L01FX05
Manufacturer: Takeda Pharma A/S
-
Blincyto 38.5 mcg powder for concentrate for solution for infusion
Form: powder for concentrate and solution for infusion
Active substance Dosage BLINATUMOMAB 38,5 µg ATC code: L01F, L01FX, L01FX07
Manufacturer: Amgen Europe B.V.
-
Columvi 10 mg concentrate for solution for infusion
Form: solution for infusion, concentrate
Active substance Dosage GLOFITAMAB 10 mg ATC code: L01F, L01FX, L01FX28
Manufacturer: Roche Registration Gmbh
-
Columvi 2.5 mg concentrate for solution for infusion
Form: solution for infusion, concentrate
Active substance Dosage GLOFITAMAB 2,5 mg ATC code: L01F, L01FX, L01FX28
Manufacturer: Roche Registration Gmbh
-
Elrexfio 40 mg/ml solution for injection
Form: solution for injection
Active substance Dosage ELRANATAMAB 40 mg ATC code: L01F, L01FX, L01FX32
Manufacturer: Pfizer Europe Ma Eeig
-
EmpliCiti 400 mg powder for concentrate for solution for infusion
Form: powder for concentrate for solution for infusion
Active substance Dosage ELOTUZUMAB 400 mg ATC code: L01F, L01FX, L01FX08
Manufacturer: Bristol-Myers Squibb Pharma Eeig
-
Imjudo 20 mg/ml concentrate for solution for infusion
Form: solution for infusion, concentrate
Active substance Dosage TREMELIMUMAB 300 mg ATC code: L01F, L01FX, L01FX20
Manufacturer: Astrazeneca Ab
-
Lunsumio 1 mg concentrate for solution for infusion
Form: solution for infusion, concentrate
Active substance Dosage MOSUNETUZUMAB 1 mg ATC code: L01F, L01FX, L01FX25
Manufacturer: Roche Registration Gmbh
-
Lunsumio 30 mg concentrate for solution for infusion
Form: solution for infusion, concentrate
Active substance Dosage MOSUNETUZUMAB 30 mg ATC code: L01F, L01FX, L01FX25
Manufacturer: Roche Registration Gmbh
-
Minjuvi 200 mg powder for concentrate for infusion solution
Form: powder for concentrate for solution for infusion
Active substance Dosage TAFASITAMAB 200 mg ATC code: L01F, L01FX, L01FX12
Manufacturer: Incyte Biosciences Distribution B.V.
-
Mylotarg 5 mg powder for concentrate for solution for infusion
Form: powder for concentrate and solution for infusion
Active substance Dosage GEMTUZUMAB OZOGAMICINE 5 mg ATC code: L01F, L01FX, L01FX02
Manufacturer: Pfizer Europe Ma Eeig
-
Padcev 20 mg powder for concentrate for solution for infusion
Form: powder for concentrate for solution for infusion
Active substance Dosage ENFORTUMAB VEDOTIN 20 mg ATC code: L01F, L01FX, L01FX13
Manufacturer: Astellas Pharma Europe B.V.
-
Padcev 30 mg powder for concentrate for solution for infusion
Form: powder for concentrate for solution for infusion
Active substance Dosage ENFORTUMAB VEDOTIN 30 mg ATC code: L01F, L01FX, L01FX13
Manufacturer: Astellas Pharma Europe B.V.
-
Polivy 140 mg powder for concentrate for infusion solution
Form: powder for concentrate for solution for infusion
Active substance Dosage POLATUZUMAB VEDOTINA 140 mg ATC code: L01F, L01FX, L01FX14
Manufacturer: Roche Registration Gmbh
-
Polivy 30 mg powder for concentrate for solution for infusion
Form: powder for concentrate for solution for infusion
Active substance Dosage POLATUZUMAB VEDOTINA 30 mg ATC code: L01F, L01FX, L01FX14
Manufacturer: Roche Registration Gmbh
-
Poteligeo 4 mg/ml concentrate for infusion solution
Form: solution for infusion, concentrate
Active substance Dosage MOGAMULIZUMAB 20 mg ATC code: L01F, L01FX, L01FX09
Manufacturer: Kyowa Kirin Holdings B.V.
-
Qarziba 4.5 mg/ml concentrate for solution for infusion
Form: solution for infusion, concentrate
Active substance Dosage DINUTUXIMAB BETA 4,5 mg ATC code: L01F, L01FX, L01FX06
Manufacturer: Recordati Netherlands B.V.
-
Rybrevant 1600 mg solution for injection
Form: solution for injection
Active substance Dosage AMIVANTAMAB 1600 mg ATC code: L01F, L01FX, L01FX18
Manufacturer: Janssen-Cilag International N.V
-
Rybrevant 2240 mg solution for injection
Form: solution for injection
Active substance Dosage AMIVANTAMAB 2240 mg ATC code: L01F, L01FX, L01FX18
Manufacturer: Janssen-Cilag International N.V
-
Rybrevant 350 mg concentrate for infusion solution
Form: solution for infusion, concentrate
Active substance Dosage AMIVANTAMAB 350 mg ATC code: L01F, L01FX, L01FX18
Manufacturer: Janssen-Cilag International N.V
-
Talvey 2 mg/ml solution for injection
Form: solution for injection
Active substance Dosage TALQUETAMAB 3 mg ATC code: L01F, L01FX, L01FX29
Manufacturer: Janssen-Cilag International N.V
-
Talvey 40 mg/ml solution for injection
Form: solution for injection
Active substance Dosage TALQUETAMAB 40 mg ATC code: L01F, L01FX, L01FX29
Manufacturer: Janssen-Cilag International N.V
-
Tecvayli 10 mg/ml solution for injection
Form: solution for injection
Active substance Dosage TECLISTAMAB 30 mg ATC code: L01F, L01FX, L01FX24
Manufacturer: Janssen-Cilag International N.V
-
Tecvayli 90 mg/ml solution for injection
Form: solution for injection
Active substance Dosage TECLISTAMAB 153 mg ATC code: L01F, L01FX, L01FX24
Manufacturer: Janssen-Cilag International N.V
-
Tepkinly 4 mg/0.8 ml solution for injection
Form: solution for injection, concentrate
Active substance Dosage EPCORITAMAB 5 mg/ml ATC code: L01F, L01FX, L01FX27
Manufacturer: Abbvie Deutschland Gmbh & Co. Kg
-
Tepkinly 48 mg solution for injection
Form: solution for injection
Active substance Dosage EPCORITAMAB 60 mg/ml ATC code: L01F, L01FX, L01FX27
Manufacturer: Abbvie Deutschland Gmbh & Co. Kg
-
Trodelvy 200 mg powder for concentrate for solution for infusion
Form: powder for concentrate for solution for infusion
Active substance Dosage SACITUZUMAB GOVITECAN 200 mg ATC code: L01F, L01FX, L01FX17
Manufacturer: Gilead Sciences Ireland Unlimited Company
-
Yervoy 5 mg/ml concentrate for solution for infusion
Form: solution for infusion, concentrate
Active substance Dosage IPILIMUMAB 213 mg ATC code: L01F, L01FX, L01FX04
Manufacturer: Bristol-Myers Squibb Pharma Eeig
-
Yervoy 5 mg/ml concentrate for solution for infusion
Form: solution for infusion, concentrate
Active substance Dosage IPILIMUMAB 53,5 mg ATC code: L01F, L01FX, L01FX04
Manufacturer: Bristol-Myers Squibb Pharma Eeig